Biogen quarterly sales rise 9 percent

Biogen Inc reported a 9 percent rise in quarterly revenue on Tuesday, helped by demand for its spinal muscular atrophy drug Spinraza.

from Reuters: Business News https://ift.tt/2LJP0nc